Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing nerve activation in spinal cord stimulation for chronic pain

Official title: Assessment of Neuronal Activation Accuracy and Stimulation Sensation in Patients with Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy

Run by AZ Delta · NCT06775535 · Data updated 2026-11-12

This study looks at how different settings on a spinal cord stimulator affect nerve activity and sensations in patients with chronic pain to help improve pain management.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment12 (estimated)
SponsorAZ Delta
Academic / other
Locations1 site (Roeselare)
StatusRecruiting
StartedAugust 2, 2023
Main results expectedAugust 2028
Study endsDecember 2029
Registry record updatedJanuary 15, 2025
Trial IDNCT06775535 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with chronic pain rated at least 5/10 on a numeric scale who are suitable for spinal cord stimulation.

Probably not a fit

Patients with active implantable devices or those unable to understand the study procedures may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows patients with chronic pain who are undergoing a trial phase for the Evoke spinal cord stimulator. It aims to evaluate how different stimulation settings influence nerve activation and the resulting sensations experienced by the patients. By monitoring these parameters, the study seeks to improve the understanding of closed-loop spinal cord stimulation therapy and its effectiveness in managing chronic pain.

Why it matters

Potential benefit: If successful, this study could enhance the effectiveness of spinal cord stimulation therapy for chronic pain patients.

How similar studies have gone: While similar studies have explored spinal cord stimulation, this specific approach focusing on neuronal activation accuracy is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject is deemed a suitable candidate for SCS trial and permanent implant and has been routinely scheduled to undergo an SCS trial phase with the Evoke SCS System.
* Subject has a minimum of pain intensity of 5/10 on the numeric rating scale (NRS) at baseline
* Subject is ≥ 18 years old.
* Subject is not pregnant or nursing.
* Subject is willing and capable of giving informed consent.

Exclusion Criteria:

* Subject currently has an active implantable device including pacemakers, spinal cord stimulator or intrathecal drug delivery system.
* Subject is incapable of understanding or responding to the study questionnaires.
* Subject is incapable of understanding or operating the patient programmer handset.

Where it's running

  • AZ Delta
    Roeselare, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.